HIMS
As seen on the 24/7 Wall St. homepage on July 24, 2026.
Regular session
$29.18
-12.82%
open $33.47
FDA restrictions on compounded weight-loss drugs and Amazon's new GLP-1 program are crushing the telehealth player's key growth engine.
Mentioned: HIMS